908 DEVICES INC (MASS)

What's going on in today's after hours session

Which stocks are moving after the closing bell on Tuesday?

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

908 Devices to Participate in Upcoming Investor Conferences

908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024

908 Devices to Participate in Craig-Hallum Bioprocessing Conference

MASS Stock Earnings: 908 Devices Misses EPS, Beats Revenue for Q2 2024

MASS stock results show that 908 Devices missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook

908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference

908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024

908 Devices is Now Oversold (MASS)

908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

908 Devices to Participate in Upcoming Investor Conferences

MASS Makes Bullish Cross Above Critical Moving Average

MASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024

MASS stock results show that 908 Devices beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform

908 Devices to Participate in Upcoming Investor Conferences

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Commit To Buy 908 Devices At $5, Earn 14.4% Annualized Using Options

908 Devices CFO Joe Griffith discloses sale of 6K shares (NASDAQ:MASS)

CFO of 908 Devices sells 6,000 shares for $72,480 as MASS stock declines by 7.9%.

Notable Thursday Option Activity: MASS, UNH, QCOM

2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street

Wall Street is uber-bullish on these two Ark Invest holdings.

3 Russell 2000 Stocks That Are About to Get Absolutely Crushed

The Russell 2000 has only begun closing its wide gap with other indices, but investors should be weary of these three stocks to sell.

908 Devices Announces MX908 Integration Capabilities